Global Biochips Market 2012-2016

RnRMarketResearch.com adds “Global Biochips Market 2012-2016”new report on its database.

TechNavio’s analysts forecast the Global Biochips market to grow at a CAGR of 19.1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing need for high speed diagnosis. The Global Biochips market has also been witnessing the high cost of deployment. However, the increasing outsourcing activities could pose a challenge to the growth of this market.

TechNavio’s report, the Global Biochips market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Biochips market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

TechNavio's Hardware team said: ''Over the years, numerous drug manufacturers have been outsourcing their drug development processes to contract research organizations. Outsourcing activities reduce manufacturing and distribution costs, ensure quality of service, and reduce lead time. They also help the sourcing companies to manage product demand and to concentrate on other competencies such as innovation and brand building. These contract research organizations employ the latest technologies and sophisticated instruments, and thus increased outsourcing to such organizations is a positive trend for the Global Biochips market.'' 

Buy a Report Copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=95868

According to the report, one of the major drivers is the growing need for high speed diagnosis from patients and doctors. Biochips are specially designed with advanced technology that makes them ultra-efficient, therefore, enhancing their operating speed to a great extent.

Further, the report states that the major challenge for the market is the high cost incurred in the implementation of biochips. The development process of biochips is lengthy as it needs to go through various stages such as design, testing, and implementation. This process is time consuming and expensive.

The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are Bio-Rad Laboratories Inc., Biomrieux Sa, Caliper Life Sciences Inc., Cephied Inc., Fluidigm Corp., Life Technologies Corp., Cybrdi Inc., Gamida For Life Group, Origene Technologies Inc., Perkinelmer Inc., Roche Nimblegen Inc., Sigma Aldrich Corp, Isu Abxis Co. Ltd, and Us Biomax Inc.

Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=95868

Table of Content

1. Executive Summary
2. List of Abbreviations
3. Introduction
4. Research Methodology
5. Market Coverage
Market Overview
Product Offerings
6. Market Landscape
6.1. Market Size and Forecast by Revenue
6.2. End-user Segmentation
6.3. Product Segmentation
6.4. Five Force Analysis
7. Geographical Segmentation
8. Key Leading Countries
9. Vendor Landscape
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Key Vendor Analysis
16.1. Affymetrix Inc.
16.1.1. Business Overview
16.1.2. Key Information
16.1.3. SWOT Analysis
16.2. Illumina, Inc.
16.2.1. Business Overview
16.2.2. Key Information
16.2.3. SWOT Analysis
16.3. Agilent Technologies Inc.
16.3.1. Business Overview
16.3.2. Key Information
16.3.3. SWOT Analysis
16.4. GE Healthcare Ltd.
16.4.1. Business Overview
16.4.2. SWOT Analysis
17. Other Reports in this Series

For more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441

Website: http://www.rnrmarketresearch.com